Peptide therapy for hyperglycemia
First Claim
Patent Images
1. A method of treating hyperglycemia comprising peripherally administering to a patient in need of the treatment a therapeutically effective amount of a composition comprising a TLQP-21 biomolecule peptide.
1 Assignment
0 Petitions
Accused Products
Abstract
Methods of modulating blood glucose levels treating hyperglycemia and related complications and conditions by administration of a VGF biomolecule to a patient in need of such treatment are provided. Methods of enhancing insulin secretion from islet beta cells in a mammal exhibiting reduced insulin secretion by administration of a therapeutically effective amount of a VGF biomolecule are also provided.
7 Citations
14 Claims
- 1. A method of treating hyperglycemia comprising peripherally administering to a patient in need of the treatment a therapeutically effective amount of a composition comprising a TLQP-21 biomolecule peptide.
- 8. A method for reducing the blood glucose concentration in a mammal comprising peripherally administering to the mammal a therapeutically effective amount of a composition comprising a TLQP-21 biomolecule peptide, wherein the mammal has a fasting blood glucose level of at least about 90 mg/dL.
Specification